The price of Mounjaro (tirzepatide) in the UK isn’t one fixed number. Most people buying privately pay per 4-week pen, and the final cost depends on dose strength, provider pricing, what’s included (consultations/support/delivery), and supply / manufacturer price changes that hit the market at different times.

If you’re new to the medication and want the full “what it is, who it’s for, how it’s used” overview, start with Mounjaro weight loss injection pen and then return here to compare costs.

Table of Contents

Typical private prices by dose (2.5mg to 15mg)

Most UK providers sell one pen that lasts 4 weeks (4 weekly doses).
Across major online providers, you’ll often see a pattern where higher strengths cost more.

Examples of publicly listed prices (to show the range you may see online):

MedExpress lists 2.5mg £179.99 up to 15mg £309.99.
Simple Online Pharmacy lists 2.5mg £169.00 up to 15mg £319.99 (and notes the pen contains four doses / 4 weeks).
Numan lists 2.5mg £229 up to 15mg £339.
Medcare Phamracy 2.5mg £135 up to £299

real examples of the spread you’ll encounter across providers.

7 things that affect the price (the “why” behind the numbers)

1) Dose strength (2.5 → 15mg)

Your dose typically increases over time, so monthly cost can rise as you move from starter to maintenance strengths. Providers commonly price higher strengths higher.

Practical takeaway:
When comparing providers, compare the exact strength you’re on (e.g., 7.5mg vs 10mg), not “Mounjaro price” as a single term.

2) What’s included in the price (consultation + follow-ups + support)

Some providers price the pen and include:

clinician eligibility assessment
check-ins or messaging support
treatment guidance and aftercare

Others separate fees (e.g., subscription/membership model, consultation add-ons, or “new patient” vs returning patient pricing). You can see “new patient price” vs subsequent pricing models on some clinic pages.

Practical takeaway:
Compare “total monthly cost,” not just the pen headline.

3) Delivery costs and dispensing model

Some providers include delivery such as Medcare Healrh Clinic; others add it at checkout. Also, “click & collect” vs home delivery can change the total. Medcare highlights convenience features like click-and-collect, which can be part of how providers differentiate (and price) their service.

4) Manufacturer list price changes (big driver since Sept 2025)

A major market shift happened when Eli Lilly announced a UK price increase effective September 2025, with the highest dose’s monthly list price rising from £122 to £330 (per Reuters reporting).
Boots also published an explainer noting Mounjaro prices increased on 1 September 2025, attributing it to the manufacturer and applying across UK providers.

Why this matters for you:
Even if two clinics used to be close in price, supplier pricing changes can widen gaps fast, and some providers update faster than others.

5) Supply and availability (shortages can change pricing and continuity)

Reuters reported a temporary halt to UK shipments in August 2025 ahead of the price increase, intended to manage supply and prevent stockpiling, with shipments resuming on September 1.
When supply tightens, you may see:

fewer dose options available
limits on switching providers
less aggressive discounting

6) Discounts, “first month” offers, and switching deals

Some clinics offer “first month” discounts (especially to attract switchers), then standard pricing afterwards. Medicspot, for example, describes discounted first-month pricing and different subsequent-month pricing for higher dose.
Reuters also reported competitive price cuts (in earlier periods) as pharmacies fought for weight-loss patients.

Practical takeaway:
If you’re budgeting long-term, calculate using month 2+ pricing, not only the introductory offer.

7) Safety/verification requirements (may affect access + process)

The UK regulator has tightened rules for online prescribing of obesity medicines, requiring stronger safeguards this can add steps to eligibility checks and verification.
It’s not always a direct price change, but it can affect:

how quickly you can start
what documentation is needed
whether some providers are stricter (and thus operate differently)

NHS vs private: does the NHS price matter to you?

If you’re paying privately, the market prices above are what you’ll typically face.

NICE recommended tirzepatide for weight management for certain patients (Dec 2024 guidance), and NHS England describes tirzepatide (Mounjaro) as a weight-loss medicine for certain eligible patients.
But NHS availability and rollout criteria/capacity mean many people still access privately.

Practical takeaway:
For private buyers, your real-world cost is driven by provider retail pricing + included services, and manufacturer list price movements can ripple across all providers.

How to compare providers properly (quick decision framework)

Compare like-for-like on 5 points

Same dose strength (2.5, 5, 7.5, 10, 12.5, 15)
What’s included (consultations, support, follow-ups)
Delivery (included or extra; speed)
Ongoing price (month 2+ pricing)
Continuity (stock reliability for your strength)

Don’t choose purely on “cheapest”

Because with injectable prescriptions, “cheapest” can become expensive if:

you can’t get your next pen on time
switching providers forces re-assessment delays
hidden fees appear later

What you should budget for (realistic expectation)

Because prices vary and move, a sensible budget approach is:

assume starter doses can be in the “high hundreds” per 4 weeks in the private market (depending on provider)
assume higher doses trend higher
build in room for manufacturer-led changes like those described in 2025 reporting

Key takeaways

Private UK prices vary mostly by dose and provider model (what’s included).
The market saw major shifts around September 2025 due to manufacturer pricing changes.
Compare providers using total monthly cost + continuity, not just the headline.
For full product context and next-step links, use the hub: Mounjaro weight loss injection pen